Literature DB >> 12680736

Triazolam-amphetamine interaction: dissociation of effects on memory versus arousal.

Miriam Z Mintzer1, Roland R Griffiths.   

Abstract

It is well-documented that benzodiazepine sedative/hypnotics produce robust dose-dependent memory-impairing effects. However, benzodiazepines also induce marked sedation, as reflected in changes in observer and subjective ratings of arousal and impaired psychomotor performance. Thus, it is possible that the observed amnestic effects are secondary to more global sedative effects, and do not reflect a specific, primary, benzodiazepine effect on memory mechanisms. This study was designed to use the non-specific stimulant d-amphetamine to dissociate the sedative and memory-impairing effects of the benzodiazepine triazolam. Across four sessions, 20 healthy adult volunteers received via oral capsule administration placebo, 0.25 mg/70 kg triazolam alone, 20 mg/70 kg d-amphetamine sulfate alone, and triazolam (0.25 mg/ 70 kg) and d-amphetamine (20 mg/70 kg) conjointly, in a double-blind, staggered dosing, cross-over design. d-Amphetamine significantly reversed the effects of triazolam on all participant rating and psychomotor performance-based measures of sedative effects, and selectively reversed the memory-impairing effects of triazolam on some measures (e.g. working memory assessed by a 2-back task, episodic memory assessed by free recall, metamemory), but not others (e.g. working memory assessed by a digit recall task, episodic memory assessed by recognition memory). Results suggest that benzodiazepines do have specific effects on memory that are not merely a by-product of the drugs' sedative effects, and that the degree to which sedative effects contribute to the amnestic effects may vary as a function of the particular memory process being assessed. In addition to enhancing the understanding of the mechanisms underlying benzodiazepine-induced amnesia, these results may also contribute to a better understanding of the complex relationship between specific memory processes and level of arousal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680736     DOI: 10.1177/0269881103017001689

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

1.  Midazolam does not inhibit association formation, just its storage and strengthening.

Authors:  Lynne M Reder; Iain Proctor; John R Anderson; Ferenc Gyulai; Joseph J Quinlan; Joyce M Oates
Journal:  Psychopharmacology (Berl)       Date:  2006-08-03       Impact factor: 4.530

2.  Relationship between drug discrimination and ratings of subjective effects: implications for assessing and understanding the abuse potential of D-amphetamine in humans.

Authors:  Anna R Reynolds; B Levi Bolin; William W Stoops; Craig R Rush
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

3.  Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers.

Authors:  Bethea A Kleykamp; Roland R Griffiths; Miriam Z Mintzer
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

4.  Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.

Authors:  Lawrence P Carter; Bethea A Kleykamp; Roland R Griffiths; Miriam Z Mintzer
Journal:  Psychopharmacology (Berl)       Date:  2012-10-25       Impact factor: 4.530

5.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

Review 6.  Wake-promoting pharmacotherapy for psychiatric disorders.

Authors:  Bernardo Dell'Osso; Cristina Dobrea; Laura Cremaschi; Chiara Arici; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

7.  Amphetamine increases errors during episodic memory retrieval.

Authors:  Michael Edward Ballard; David A Gallo; Harriet de Wit
Journal:  J Clin Psychopharmacol       Date:  2014-02       Impact factor: 3.153

8.  A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.

Authors:  D Andrew Tompkins; Michael T Smith; Miriam Z Mintzer; Claudia M Campbell; Eric C Strain
Journal:  J Pharmacol Exp Ther       Date:  2013-11-13       Impact factor: 4.030

9.  Psychoactive drugs and false memory: comparison of dextroamphetamine and δ-9-tetrahydrocannabinol on false recognition.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2011-06-07       Impact factor: 4.530

10.  SYVN1, an ERAD E3 Ubiquitin Ligase, Is Involved in GABAAα1 Degradation Associated with Methamphetamine-Induced Conditioned Place Preference.

Authors:  Dong-Liang Jiao; Yan Chen; Yao Liu; Yun-Yue Ju; Jian-Dong Long; Jiang Du; Chang-Xi Yu; Yu-Jun Wang; Min Zhao; Jing-Gen Liu
Journal:  Front Mol Neurosci       Date:  2017-10-05       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.